United States Recombinant Antibody Market Report 2017

December 2017 | 102 pages | ID: UE5D4DD33B6EN
QYResearch

Abstracts

In this report, the United States Recombinant Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Recombinant Antibody in these regions, from 2012 to 2022 (forecast).

United States Recombinant Antibody market competition by top manufacturers/players, with Recombinant Antibody sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abnova
• Medix Biochemica
• GE Healthcare
• SinoBiological
• Bioventix

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chimeric Antibody
• Humanized Antibody
• Full Human Antibody
• Single Chain Antibody
• Bispecific Antibody

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Recombinant Antibody Market Report 2017

1 RECOMBINANT ANTIBODY OVERVIEW

1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody by Product Category
  1.2.1 United States Recombinant Antibody Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Recombinant Antibody Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Chimeric Antibody
  1.2.4 Humanized Antibody
  1.2.5 Full Human Antibody
  1.2.6 Single Chain Antibody
  1.2.7 Bispecific Antibody
1.3 United States Recombinant Antibody Market by Application/End Users
  1.3.1 United States Recombinant Antibody Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Scientific Research
  1.3.4 Others
1.4 United States Recombinant Antibody Market by Region
  1.4.1 United States Recombinant Antibody Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Recombinant Antibody Status and Prospect (2012-2022)
  1.4.3 Southwest Recombinant Antibody Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Recombinant Antibody Status and Prospect (2012-2022)
  1.4.5 New England Recombinant Antibody Status and Prospect (2012-2022)
  1.4.6 The South Recombinant Antibody Status and Prospect (2012-2022)
  1.4.7 The Midwest Recombinant Antibody Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Recombinant Antibody (2012-2022)
  1.5.1 United States Recombinant Antibody Sales and Growth Rate (2012-2022)
  1.5.2 United States Recombinant Antibody Revenue and Growth Rate (2012-2022)

2 UNITED STATES RECOMBINANT ANTIBODY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Recombinant Antibody Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Recombinant Antibody Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Recombinant Antibody Average Price by Players/Suppliers (2012-2017)
2.4 United States Recombinant Antibody Market Competitive Situation and Trends
  2.4.1 United States Recombinant Antibody Market Concentration Rate
  2.4.2 United States Recombinant Antibody Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Recombinant Antibody Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RECOMBINANT ANTIBODY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Recombinant Antibody Sales and Market Share by Region (2012-2017)
3.2 United States Recombinant Antibody Revenue and Market Share by Region (2012-2017)
3.3 United States Recombinant Antibody Price by Region (2012-2017)

4 UNITED STATES RECOMBINANT ANTIBODY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Recombinant Antibody Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Recombinant Antibody Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Antibody Price by Type (2012-2017)
4.4 United States Recombinant Antibody Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RECOMBINANT ANTIBODY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Recombinant Antibody Sales and Market Share by Application (2012-2017)
5.2 United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RECOMBINANT ANTIBODY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abnova
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Antibody Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abnova Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Medix Biochemica
  6.2.2 Recombinant Antibody Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Medix Biochemica Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GE Healthcare
  6.3.2 Recombinant Antibody Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GE Healthcare Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 SinoBiological
  6.4.2 Recombinant Antibody Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 SinoBiological Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bioventix
  6.5.2 Recombinant Antibody Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bioventix Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 RECOMBINANT ANTIBODY MANUFACTURING COST ANALYSIS

7.1 Recombinant Antibody Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Antibody

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RECOMBINANT ANTIBODY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Recombinant Antibody Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Recombinant Antibody Sales Volume Forecast by Type (2017-2022)
11.3 United States Recombinant Antibody Sales Volume Forecast by Application (2017-2022)
11.4 United States Recombinant Antibody Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Recombinant Antibody
Figure United States Recombinant Antibody Market Size (K Pcs) by Type (2012-2022)
Figure United States Recombinant Antibody Sales Volume Market Share by Type (Product Category) in 2016
Figure Chimeric Antibody Product Picture
Figure Humanized Antibody Product Picture
Figure Full Human Antibody Product Picture
Figure Single Chain Antibody Product Picture
Figure Bispecific Antibody Product Picture
Figure United States Recombinant Antibody Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Recombinant Antibody by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Recombinant Antibody Market Size (Million USD) by Region (2012-2022)
Figure The West Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Antibody Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Recombinant Antibody Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Recombinant Antibody Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Antibody Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Antibody Sales Share by Players/Suppliers
Figure United States Recombinant Antibody Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Recombinant Antibody Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Recombinant Antibody Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Antibody Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Antibody Revenue Share by Players/Suppliers
Table United States Market Recombinant Antibody Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Recombinant Antibody Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Recombinant Antibody Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Antibody Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Antibody Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Antibody Product Category
Table United States Recombinant Antibody Sales (K Pcs) by Region (2012-2017)
Table United States Recombinant Antibody Sales Share by Region (2012-2017)
Figure United States Recombinant Antibody Sales Share by Region (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Region in 2016
Table United States Recombinant Antibody Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Recombinant Antibody Revenue Share by Region (2012-2017)
Figure United States Recombinant Antibody Revenue Market Share by Region (2012-2017)
Figure United States Recombinant Antibody Revenue Market Share by Region in 2016
Table United States Recombinant Antibody Price (USD/Pcs) by Region (2012-2017)
Table United States Recombinant Antibody Sales (K Pcs) by Type (2012-2017)
Table United States Recombinant Antibody Sales Share by Type (2012-2017)
Figure United States Recombinant Antibody Sales Share by Type (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Type in 2016
Table United States Recombinant Antibody Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type in 2016
Table United States Recombinant Antibody Price (USD/Pcs) by Types (2012-2017)
Figure United States Recombinant Antibody Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Antibody Sales (K Pcs) by Application (2012-2017)
Table United States Recombinant Antibody Sales Market Share by Application (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Application (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Application in 2016
Table United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Table Abnova Basic Information List
Table Abnova Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Recombinant Antibody Sales Growth Rate (2012-2017)
Figure Abnova Recombinant Antibody Sales Market Share in United States (2012-2017)
Figure Abnova Recombinant Antibody Revenue Market Share in United States (2012-2017)
Table Medix Biochemica Basic Information List
Table Medix Biochemica Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Medix Biochemica Recombinant Antibody Sales Growth Rate (2012-2017)
Figure Medix Biochemica Recombinant Antibody Sales Market Share in United States (2012-2017)
Figure Medix Biochemica Recombinant Antibody Revenue Market Share in United States (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GE Healthcare Recombinant Antibody Sales Growth Rate (2012-2017)
Figure GE Healthcare Recombinant Antibody Sales Market Share in United States (2012-2017)
Figure GE Healthcare Recombinant Antibody Revenue Market Share in United States (2012-2017)
Table SinoBiological Basic Information List
Table SinoBiological Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SinoBiological Recombinant Antibody Sales Growth Rate (2012-2017)
Figure SinoBiological Recombinant Antibody Sales Market Share in United States (2012-2017)
Figure SinoBiological Recombinant Antibody Revenue Market Share in United States (2012-2017)
Table Bioventix Basic Information List
Table Bioventix Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bioventix Recombinant Antibody Sales Growth Rate (2012-2017)
Figure Bioventix Recombinant Antibody Sales Market Share in United States (2012-2017)
Figure Bioventix Recombinant Antibody Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Players/Suppliers in 2016
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure United States Recombinant Antibody Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Antibody Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Recombinant Antibody Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Recombinant Antibody Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Antibody Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Antibody Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources